Loading clinical trials...
Loading clinical trials...
A Randomized Study of the Clinical and Economic Impact of Remote Monitoring Program With Disease Management Compared to Conventional Diabetes Disease Management Interventions
The primary objective of this study is to determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease than a standard disease management program.
To determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease.
Age
18 - 64 years
Sex
ALL
Healthy Volunteers
No
Marietta, Georgia, United States
Start Date
March 1, 2008
Primary Completion Date
December 1, 2009
Completion Date
December 1, 2009
Last Updated
December 18, 2009
300
ESTIMATED participants
DM-Standard
BEHAVIORAL
Disease Management Plus
BEHAVIORAL
Lead Sponsor
LifeScan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06671587